IP Verse

Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation

Patent No. EP3453403 (titled "Dpp-Iv Inhibitor Combined With A Further Antidiabetic Agent, Tablets Comprising Such Formulations, Their Use And Process For Their Preparation") was filed by Boehringer Ingelheim on Apr 2, 2009. The application was issued on Jan 22, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
LUIGIOct 21, 2025TER MEER STEINMEISTER & PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3453403

BOEHRINGER INGELHEIM
Application Number
EP18195610A
Filing Date
Apr 2, 2009
Status
Granted And Under Opposition
Dec 20, 2024
Publication Date
Jan 22, 2025
External Links
Slate, Register , Google Patents